LRRK2 and Parkinson disease: Importantly, it has been reported that LRRK2 harboring familial Parkinson mutations exhibits reduced cellular phosphorylation by an unknown mechanism, implicating the disturbed cellular phosphorylation in the toxic mechanism of familial Parkinson mutant LRRK2 [16].